Patients are encouraged to discuss the balance between disease control and the toxic long-term effects of maintenance drugs with their oncology team.
Early versus Late Discontinuation of Maintenance Therapy in ... - MDPI IFM_05-May 2022
Research published around May 2022 explored the impact of "early" vs. "late" discontinuation (stopping before or after 3 years), noting that early stopping is often forced by toxicity rather than choice. Patients are encouraged to discuss the balance between